SYNALGOS-DC Drug Patent Profile
Which patents cover Synalgos-dc, and when can generic versions of Synalgos-dc launch?
Synalgos-dc is a drug marketed by Sun Pharm Industries and Leitner Pharms and is included in two NDAs.
The generic ingredient in SYNALGOS-DC is acetaminophen; caffeine; dihydrocodeine bitartrate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SYNALGOS-DC?
- What are the global sales for SYNALGOS-DC?
- What is Average Wholesale Price for SYNALGOS-DC?
Summary for SYNALGOS-DC
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 32 |
| DailyMed Link: | SYNALGOS-DC at DailyMed |
US Patents and Regulatory Information for SYNALGOS-DC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | SYNALGOS-DC | aspirin; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 011483-004 | Sep 6, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Leitner Pharms | SYNALGOS-DC-A | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 089166-001 | May 14, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
